» Articles » PMID: 33991317

Reduced Th1 Response is Associated with Lower Glycolytic Activity in Activated Peripheral Blood Mononuclear Cells After Metabolic and Bariatric Surgery

Overview
Publisher Springer
Specialty Endocrinology
Date 2021 May 15
PMID 33991317
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Obesity promotes cellular immunometabolism changes that trigger the activation of macrophages and lymphocytes, leading to systemic inflammation. Activated leukocytes undergo metabolic reprogramming, increasing glycolytic activity.

Objective: To examine whether the reduction in the inflammatory state associated with bariatric surgery is associated with decreased glycolytic activity in leukocytes. Setting Single-center, prospective observational study.

Methods: This study involved 18 patients with obesity undergoing bariatric surgery. All measurements were performed preoperatively and six months postoperatively. Peripheral blood mononuclear cells and plasma were obtained to determine the glycolytic rate and mitochondrial membrane potential as surrogates of the metabolic switching and high-sensitivity C-reactive protein, adipokines, and CD69 expression as inflammatory and activation markers.

Results: Glycolytic activity engaged by CD3/CD28 activation was reduced six months after bariatric surgery, associated with decreased levels of T helper (Th) 1 and Th17 signature cytokines. An overall reduction in inflammatory markers was observed, which correlated with a higher adiponectin/leptin ratio.

Conclusions: Metabolic and bariatric surgery-induced weight loss leads to reprogramming in T cells' metabolic machinery, resulting in reduced stimulation of glycolysis after activation, which may explain the decrease in systemic inflammation mediated by cytokines such as interferon-γ and interleukin-17A.

Citing Articles

Central and Peripheral Inflammation: A Common Factor Causing Addictive and Neurological Disorders and Aging-Related Pathologies.

Escobar A, Bonansco C, Cruz G, Dagnino-Subiabre A, Fuenzalida M, Negron I Int J Mol Sci. 2023; 24(12).

PMID: 37373230 PMC: 10298583. DOI: 10.3390/ijms241210083.


The role of Th17 cells in endocrine organs: Involvement of the gut, adipose tissue, liver and bone.

Zi C, Wang D, Gao Y, He L Front Immunol. 2023; 13:1104943.

PMID: 36726994 PMC: 9884980. DOI: 10.3389/fimmu.2022.1104943.


Impact of Roux-en-Y Gastric Bypass on Mitochondrial Biogenesis and Dynamics in Leukocytes of Obese Women.

Abad-Jimenez Z, Vezza T, Lopez-Domenech S, Fernandez-Reyes M, Canet F, Morillas C Antioxidants (Basel). 2022; 11(7).

PMID: 35883794 PMC: 9312345. DOI: 10.3390/antiox11071302.


Depression and Obesity in Patients With Psoriasis and Psoriatic Arthritis: Is IL-17-Mediated Immune Dysregulation the Connecting Link?.

Zafiriou E, Daponte A, Siokas V, Tsigalou C, Dardiotis E, Bogdanos D Front Immunol. 2021; 12:699848.

PMID: 34367160 PMC: 8334867. DOI: 10.3389/fimmu.2021.699848.

References
1.
Jia L, Zhao J, Yang C, Liang Y, Long P, Liu X . Severe Pneumonia Caused by Coinfection With Influenza Virus Followed by Methicillin-Resistant Induces Higher Mortality in Mice. Front Immunol. 2019; 9:3189. PMC: 6364753. DOI: 10.3389/fimmu.2018.03189. View

2.
Fuster J, Ouchi N, Gokce N, Walsh K . Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. Circ Res. 2016; 118(11):1786-807. PMC: 4887147. DOI: 10.1161/CIRCRESAHA.115.306885. View

3.
Belizario J, Faintuch J, Garay-Malpartida M . Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases. Mediators Inflamm. 2019; 2018:2037838. PMC: 6304917. DOI: 10.1155/2018/2037838. View

4.
Rocha V, Folco E, Sukhova G, Shimizu K, Gotsman I, Vernon A . Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res. 2008; 103(5):467-76. PMC: 2740384. DOI: 10.1161/CIRCRESAHA.108.177105. View

5.
Shi L, Wang R, Huang G, Vogel P, Neale G, Green D . HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med. 2011; 208(7):1367-76. PMC: 3135370. DOI: 10.1084/jem.20110278. View